Skip to main content
Premium Trial:

Request an Annual Quote

NeuMoDx Molecular Receives CE Mark for Quantitative BK Viral Assay

NEW YORK – NeuMoDx Molecular announced on Wednesday that it has received the CE mark for its viral load monitoring assay.

In collaboration with Milan, Italy-based Sentinel Diagnostics, NeuMoDx developed the Quantitative BK virus (BKV) assay, which is intended to help clinical manage infection in the critical organ transplant patient population. The partnership strengthens the NeuMoDx transplant menu, which already includes tests with CE mark for Epstein–Barr virus and cytomegalovirus viral load monitoring for the management of immunocompromised patients, NeuMoDx said.

The Quantitative BKV virus assay is based on Sentinel Diagnostics' STAT-NAT patented technology and is available in a ready-to-use lyophilized format. The assay is stable at room temperature for two years and provides state of the art performance, according to Ann Arbor, Michigan-based NeuMoDx.

"The availability of the NeuMoDx BKV Quant Assay, along with the previously commercialized NeuMoDx CMV and EBV Quant Assays, moves us significantly closer to providing a comprehensive transplant virology monitoring solution," NeuMoDx President and Chief Operating Officer Sundu Brahmasandra said in a statement.

From extraction to detection, the assay integrates the entire molecular diagnostic process with the first results available in about 60 minutes for viral load tests, NeuMoDx said.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.